SYDNEY BARRINGTON: Open Payments
NPI 1659960763 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$850 in 28 payments from 10 companies in 2025. Trend: 2023 $666 · 2024 $1,406 · 2025 $850
Food & beverage: $850
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $293 |
| Sumitomo Pharma America, Inc. | 5 | $101 |
| Janssen Scientific Affairs, LLC | 2 | $100 |
| UROGEN PHARMA, INC. | 4 | $87 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| Astellas Pharma US Inc | 2 | $43 |
| IMMUNITYBIO, INC. | 2 | $32 |
| PFIZER INC. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: ERLEADA, ORGOVYX, Nubeqa, Xtandi, KEYTRUDA, ANKTIVA, WELIREG, GEMTESA.
Industry payments across VA — which companies pay providers there.
